Cargando…

Metabolic Fingerprint in Hereditary Spherocytosis Correlates With Red Blood Cell Characteristics and Clinical Severity

Detalles Bibliográficos
Autores principales:	van Dooijeweert, Birgit, Broeks, Melissa H., Verhoeven-Duif, Nanda M., van Solinge, Wouter W., van Beers, Eduard J., Rab, Minke A. E., Nieuwenhuis, Edward E. S., Jans, Judith J. M., Bartels, Marije, van Wijk, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196084/ https://www.ncbi.nlm.nih.gov/pubmed/34131631 http://dx.doi.org/10.1097/HS9.0000000000000591

Ejemplares similares

Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia
por: van Dooijeweert, Birgit, et al.
Publicado: (2021)

Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency
por: van Dooijeweert, Birgit, et al.
Publicado: (2020)

The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients: Genotype-Phenotype Correlation in Hereditary Spherocytosis
por: van Vuren, Annelies, et al.
Publicado: (2019)

The Interplay between Drivers of Erythropoiesis and Iron Homeostasis in Rare Hereditary Anemias: Tipping the Balance
por: Grootendorst, Simon, et al.
Publicado: (2021)

Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis
por: Huisjes, Rick, et al.
Publicado: (2020)

Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis
por: Berrevoets, M. C., et al.
Publicado: (2021)

GATA-1 Defects in Diamond–Blackfan Anemia: Phenotypic Characterization Points to a Specific Subset of Disease
por: van Dooijeweert, Birgit, et al.
Publicado: (2022)

Transfusion burden in early childhood plays an important role in iron overload in Diamond‐Blackfan anaemia
por: de Wilde, Jonathan R. A., et al.
Publicado: (2022)

P1424: ONE-YEAR FOLLOW-UP OF A PHASE 2 STUDY OF MITAPIVAT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR THE TREATMENT OF SICKLE CELL DISEASE
por: van Dijk, Myrthe, et al.
Publicado: (2023)

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
por: van Vuren, Annelies J., et al.
Publicado: (2021)

Hereditary Spherocytosis
por: Huq, Sayeeda, et al.
Publicado: (2010)

The fluid membrane determines mechanics of erythrocyte extracellular vesicles and is softened in hereditary spherocytosis
por: Vorselen, Daan, et al.
Publicado: (2018)

Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia
por: Sheehan, Vivien A., et al.
Publicado: (2022)

P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
por: de Wilde, Jonathan, et al.
Publicado: (2023)

Red blood cell vesiculation in hereditary hemolytic anemia
por: Alaarg, Amr, et al.
Publicado: (2013)

Hereditary spherocytosis and allied disorders
por: Russo, Roberta, et al.
Publicado: (2019)

AG-348 (mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and adenosine triphosphate levels over a broad range of PKLR genotypes
por: Rab, Minke A.E., et al.
Publicado: (2020)

Inborn disorders of the malate aspartate shuttle
por: Broeks, Melissa H., et al.
Publicado: (2021)

Extramedullary paraspinal hematopoiesis in hereditary spherocytosis
por: Gogia, P., et al.
Publicado: (2008)

Hereditary spherocytosis: Consequences of delayed diagnosis
por: Steward, Sarah C, et al.
Publicado: (2014)

Paravertebral pseudotumor in patient with hereditary spherocytosis
por: Rabelo, Lêda Maria, et al.
Publicado: (2016)

P1481: SYSTEMATICALLY REDUCED RED CELL PHOSPHATIDYLSERINE FLIPPASE ACTIVITY IS SUFFICIENT TO INDUCE HEREDITARY HEMOLYTIC ANEMIA
por: van Dijk, Myrthe, et al.
Publicado: (2023)

PI-02: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: M., VAN DIJK, et al.
Publicado: (2022)

Subtotal Splenectomy in Hereditary Spherocytosis - Advantages and Disadvantages
por: BICĂ, C., et al.
Publicado: (2016)

The Spectrum of SPTA1-Associated Hereditary Spherocytosis
por: Chonat, Satheesh, et al.
Publicado: (2019)

The diagnostic protocol for hereditary spherocytosis‐2021 update
por: Wu, Yangyang, et al.
Publicado: (2021)

Genotype-degree of hemolysis correlation in hereditary spherocytosis
por: Shi, Yimeng, et al.
Publicado: (2023)

Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial
por: van Vuren, Annelies, et al.
Publicado: (2022)

P1500: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
por: van der Veen, S., et al.
Publicado: (2022)

P-023: 2,3-DIPHOSPHOGLYCERATE DETECTION VIA DIRECT INFUSION HIGH RESOLUTION MASS SPECTROMETRY CORRELATES WITH QUANTITATIVE DETECTION IN BLOOD OF PATIENTS WITH SICKLE CELL DISEASE
por: S., VAN DER VEEN, et al.
Publicado: (2022)

P1527: NEXT GENERATION SEQUENCING IN HEREDITARY SPHEROCYTOSIS DIAGNOSIS
por: García Feria, A., et al.
Publicado: (2022)

A case of concomitant Gilbert's syndrome and hereditary spherocytosis
por: Lee, Hee Jung, et al.
Publicado: (2010)

α-thalassaemia combined with hereditary spherocytosis in the same patient
por: Li, Xiaohong, et al.
Publicado: (2018)

Blood cell parameters for screening and diagnosis of hereditary spherocytosis
por: Liao, Lin, et al.
Publicado: (2019)

Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis
por: Chonat, Satheesh, et al.
Publicado: (2019)

Hereditary Spherocytosis as an Atypical Presentation of Anemia in Ulcerative Colitis
por: Cho, Moo, et al.
Publicado: (2021)

Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis.
por: Lee, Y. K., et al.
Publicado: (2000)

PB2518: OPTIMIZING THE DETECTION OF 2,3- DIPHOSPHOGLYCERATE IN DRIED BLOOD SPOTS OF PATIENTS WITH SICKLE CELL DISEASE: UNTARGETED METABOLOMICS WITHIN THE GENOMED4ALL PROJECT
por: van der Veen, Sigrid, et al.
Publicado: (2023)

PB2509: RED BLOOD CELL PYRUVATE KINASE PROPERTIES IN SICKLE CELL DISEASE – OF MICE AND MEN
por: Traets, Marissa, et al.
Publicado: (2023)

Anaesthetic management of a case of hereditary spherocytosis for splenectomy and cholecystectomy
por: Chaithanya, Krishna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_61s6n89rufoai5kqluspmrndc3